Upload Avatar (500 x 500)
Lei Miao
lmiao_pharm@bjmu.edu.cn
English, Chinese
Beijing
Peking University
Pharmaceutical Sciences
  • 2022 - present: Researcher, Peking University School of Pharmaceutical Sciences
  • 2012.8-2016.5: Ph.D. in Science, University of North Carolina at Chapel Hill
  • 2008.9-2012.7: B.Sc. in Science, Shandong University School of Pharmacy
  • 2022 - present: Researcher, Peking University School of Pharmaceutical Sciences
  • 2019.5-2022.3: Senior Researcher, Gilead Sciences Formulation Development Department
  • 2018.10-2019.5: ORISE Fellow, US FDA
  • 2016.8-2019.5: Postdoctoral Researcher, Koch Institute for Integrative Cancer Research, MIT
Pharmaceutics
Nanomedicine
  • Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver, Miao L., Lin J., Huang Y., Li L., Delcassian D., Ge Y., Shi Y., Anderson D.G., 2020
  • Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation, Miao L., Li L., Huang Y., Delcassian D., Chahal J., Han J., Shi Y., Sadtler K., Gao W., Lin J., Doloff J.C., Langer R., Anderson D.G., 2019
  • Transient and local expression of chemokine and immune checkpoint traps to treat pancreatic cancer, Miao L., Li J., Liu Q., Feng R., Das M., Lin C.M., Goodwin T.J., Dorosheva O., Liu R., Huang L., 2017
  • Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy, Lu X., Miao L., Gao W., Chen Z., McHugh K.J., Sun Y., Tochka Z., Tomasic S., Sadtler K., Hyacinthe A., Huang Y., Graf T., Hu Q., Sarmadi M., Langer R., Anderson D.G., Jaklenec A., 2020
  • Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors, Miao L., Liu Q., Lin C.M., Luo C., Wang Y., Liu L., Yin W., Hu S., Kim W.Y., Huang L., 2017
Drug Delivery Gene Therapy Nanotechnology Cancer Immunotherapy Targeted Therapy Mrna Vaccines Lipid Nanoparticles Tumor Microenvironment Immune Cell Activation Chemokine Expression

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.